The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 18, 2022
Filed:
Nov. 13, 2020
Applicant:
Shenzhen Pharmacin Co., Ltd., Shenzhen, CN;
Inventors:
Zeren Wang, Southbury, CT (US);
Shun Chen, Shenzhen, CN;
Longwei Sun, Shenzhen, CN;
Yanxin Zhao, Shenzhen, CN;
Assignee:
Shenzhen Pharmacin Co., Ltd., Shenzhen, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/48 (2006.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01); A61K 47/02 (2006.01); A61P 35/00 (2006.01); A61K 9/14 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
A61K 9/4866 (2013.01); A61K 9/14 (2013.01); A61K 9/485 (2013.01); A61K 9/4858 (2013.01); A61K 31/519 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/32 (2013.01); A61P 35/00 (2018.01);
Abstract
Provided are amorphous solid dispersions comprising an active pharmaceutical ingredient and pharmaceutical compositions comprising the amorphous solid dispersions. Also described herein are methods for preparing and using such compositions. In some embodiments, an amorphous solid dispersion comprises an active pharmaceutical ingredient such as palbociclib or neratinib, one or more acids, and a high-molecular weight material.